CIK 0001840706 · Accelerated filer<br>Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- other
- Phone
- 41 21 694 10 60
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- Open-market buys, last 90 days
- $278,388
- in 2 filings
- Open-market sales, last 90 days
- $1,679,030
- in 28 filings, $1.6M under 10b5-1 plans
Net −$1,400,642. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 34 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | HIBBS KATHY L Director | Sale 10b5-1 | −6,250 | $7.76 | $48K | 90,742 |
| 2026-11-10 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −8,500 | $7.76 | $66K | 3,378,650 |
| 2026-11-09 | Van Well Daan Chief Legal Officer | Sale 10b5-1 | −1,411 | $7.44 | $10K | 331,305 |
| 2026-11-06 | CARDOZA GEORGE Chief Financial Officer | Purchase | +20,000 | $7.06 | $141K | 326,726 |
| 2026-11-06 | Muken Ross Chief Executive Officer | Purchase | +20,000 | $6.86 | $137K | 680,391 |
| 2026-10-13 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −4,000 | $7.18 | $29K | 541,493 |
| 2026-10-12 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −5,000 | $7.26 | $36K | 195,993 |
| 2026-10-12 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −8,500 | $7.26 | $62K | 3,387,150 |
| 2026-10-05 | Van Well Daan Chief Legal Officer | Sale 10b5-1 | −6,168 | $8.12 | $50K | 332,716 |
| 2026-10-05 | Valente Manuela Chief People Officer | Sale 10b5-1 | −4,240 | $8.13 | $34K | 206,210 |
| 2026-10-05 | Verma Abhimanyu Chief Technology Officer | Sale 10b5-1 | −5,284 | $8.12 | $43K | 166,887 |
| 2026-10-05 | Puylaert Kevin Chief Sales Officer | Sale | −185 | $8.06 | $1K | 147,763 |
| 2026-10-05 | Puylaert Kevin Chief Sales Officer | Sale | −31 | $7.92 | $246 | 147,732 |
| 2026-10-05 | CARDOZA GEORGE Chief Financial Officer | Sale 10b5-1 | −1,592 | $8.10 | $13K | 306,726 |
| 2026-10-05 | Menu Philippe Chief Medical Officer | Sale 10b5-1 | −7,394 | $8.13 | $60K | 200,993 |
| 2026-10-05 | Camblong Jurgi Executive Chairman | Sale 10b5-1 | −40,172 | $8.13 | $327K | 3,395,650 |
| 2026-10-05 | Xu Zhenyu Chief Scientific Officer | Sale 10b5-1 | −7,394 | $8.12 | $60K | 545,493 |
| 2026-10-05 | Muken Ross Chief Executive Officer | Sale 10b5-1 | −9,838 | $8.13 | $80K | 660,391 |
| 2026-09-21 | CARDOZA GEORGE Chief Financial Officer | Sale 10b5-1 | −774 | $8.33 | $6K | 308,318 |
| 2026-09-21 | Muken Ross Chief Executive Officer | Sale 10b5-1 | −422 | $8.33 | $4K | 670,229 |
Page 1 of 8 · 157 trades